Prevalence of latent tuberculosis infection in inmates recently incarcerated in a men's prison in Barcelona

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 1, 2012, Pages 60-64

  Marco, Andrés ^a   Sole N ^a   Orcau, A ^b   Escribano, M ^a   Del Bano L ^b   Quintero, S ^a   Cayla J A ^b  

^a Health Services of Barcelona Men's Penitentiary Centre   (Spain)

^b AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

Prisons; Screening; Tuberculin skin test; Tuberculosis prevention and control

Indexed keywords

COCAINE; DIAMORPHINE; TUBERCULIN;

ADULT; AFRICA SOUTH OF THE SAHARA; AGE; ARTICLE; COCAINE DEPENDENCE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EASTERN EUROPE; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORTH AFRICA; PREVALENCE; PRIORITY JOURNAL; PRISON; PRISONER; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SOUTH AND CENTRAL AMERICA; SPAIN; TUBERCULIN TEST;

ADULT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHI-SQUARE DISTRIBUTION; COINFECTION; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; HIV INFECTIONS; HUMANS; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; MASS SCREENING; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRISONERS; PRISONS; RISK ASSESSMENT; RISK FACTORS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; TUBERCULIN TEST;

EID: 84555194779     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0007     Document Type: Article

References (41)

1. World Health Organization. Global tuberculosis control. WHO report 2010. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/ publications/2010/9789241564069-eng.pdf Accessed October 2011.
2. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 Global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/publications/2010/ 9789241599191-eng.pdf Accessed October 2011.
3. Martín V, Reyes H. Tuberculosis extensivamente resistente y la población privada de libertad. Res Esp Sanid Penit 2011; 13: 1-2. [Spanish]
4. Rodrigo T, Caylà J A, Galdós-Tangüis H, Garcia de Olalla P, Brugal M T, Jansà J M. Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis 2001; 5: 432-440. (Pubitemid 32397567)
5. Orcau A, Caylà J A. La tuberculosi. In: La salud de la poblacióimigrant de Barcelona. Barcelona, Spain: Agència de Salut Pública de Barcelona, 2008. [Catalan]
6. Bran C, Gómez i Prat J, Caylà J A, Garcia de Olalla P. Estudio de los factores asociados a la infección tuberculosa latente en inmigrantes menores de 35 años. Enferm Infecc Microbiol Clin 2006; 24: 322-325. [Spanish] (Pubitemid 43952228)
7. March F. Análisis de la transmisión de la tuberculosis en la población penitenciaria. Rev Esp Sanid Penit 1999; 1: 146-148. [Spanish]
8. Aerts A, Hauer B, Wanlin M, Veen J. Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis 2006; 10: 1215-1223. (Pubitemid 44713474)
9. Moreira-Oliveira M S, Oliveira H B, Pace F, et al. Molecular genotyping and epidemiology of Mycobacterium tuberculosis isolates obtained from inmates of correctional institutions of Campinas, Southeast Brazil. Braz J Infect Dis 2008; 12: 487-493.
10. Macintre C R, Kendig N, Kummer L, Birago S, Graham N M, Plant A J. Unrecognised transmission of tuberculosis in prisons. Eur J Epidemiol 1999; 15: 705-709. (Pubitemid 29493109)
11. March F, Coll P, Guerrero R A, Busquets E, Caylà J A, Prats G. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 2000; 14: 525-535. (Pubitemid 30209695)
12. Centers for Disease Control and Preevention (CDC). Tuberculosis transmission in multiple correctional facilities - Kansas, 2002-2003. MMWR Morb Mortal Wkly Rep 2004; 53: 734-738.
13. McLaughlin S I, Spradling P, Drociuk D, Ridzon R, Pozsik C J, Onorato I. Extensive transmission of Mycobacterium tuberculosis among congregated, HIV-infected prison inmates in South Carolina, United States. Int J Tuberc Lung Dis 2003; 7: 665-672. (Pubitemid 36806862)
14. Caylà J A, Marco A, Bedoya A, et al. Differential characteristics of AIDS patients with a history of prison internment. Int J Epidemiol 1995; 24: 1188-1196. (Pubitemid 26025031)
15. Subdirección General de Sanidad Penitenciaria. Memoria 2008. Madrid, Spain: Subdirección General de Sanidad Penitenciaria, 2008. [Spanish]
16. Martin V, López-Caleya J F, Núñez M J, Morís M L, Pérez-Vicente R, Caylà J A. [HCV and HIV infection, and co-infection in the León health area in the period 1993-2004]. Rev Esp Salud Publica 2009; 83: 533-534. [Spanish]
17. Departament de Justícia. Butlletí penitenciari 2008. Barcelona, Spain: Departament de Justícia, 2008. [Catalán]
18. Alonso F J, García-Bajo C, Lougedo M J, et al. Prevalencia de infección tuberculosa en personas inmigrantes del área de salud de Toledo. Rev Esp Salud Pública 2004; 78: 593-600. [Spanish]
19. Huerga H. Infección tuberculosa en inmigrantes procedentes de América Latina. Med Clín (Barc) 2002; 119: 117. [Spanish]
20. Iñigo J, García de Viedma D, Arce A, et al. Analysis of changes in recent tuberculosis transmission patterns after a sharp increase in immigration. J Clin Microbiol 2007; 45: 63-69. (Pubitemid 46106407)
21. Gil M, Moreno R, Marín M, Romeu M A, Gomila B, González F. Influencia de la inmigración en los patrones de transmisión de la tuberculosis en Castellón (2004-2007). Gac Sanit 2011; 25: 122-126. [Spanish]
22. World Health Organization Stop TB Department. Tuberculosis. Geneva, Switzerland: WHO, 2011. www.who.int/tb Accessed October 2011.
23. Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC. MMWR 2006; 55 (RR 9): 1-44.
24. Martin V, Gonzalez P, Caylà J A, et al. Case-finding of pulmonary tuberculosis on admission to a penitentiary centre. Tubercle Lung Dis 1994; 75: 49-53. (Pubitemid 24128760)
25. Hussain H, Akhtar S, Nanan D. Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol 2003; 32: 794-799. (Pubitemid 37304642)
26. Subdirección General de Sanidad Penitenciaria. Encuesta de 22 de junio de 1998. Madrid, Spain: Ministerio del Interior, 1998. [Spanish]
27. Lemos A C, Matos E D, Bittencourt C N. Prevalence of active and latent TB among inmates in a prison hospital in Bahia, Brazil. J Bras Pneumol 2009; 35: 63-68.
28. Carbonara S, Babudieri S, Longo B, et al. Correlates of Mycobacterium tuberculosis infection in a prison population. Eur Respir J 2005; 25: 1070-1076. (Pubitemid 40823784)
29. Butler T, Levy M. Mantoux positivity among prison inmates - New South Wales, 1996. Aust N Z J Public Health 1999; 23: 185-188. (Pubitemid 29332819)
30. Baillargeon J, Black S A, Pulvino J, Dunn K. The disease profile of Texas prison inmates. Ann Epidemiol 2000; 10: 71-73.
31. Lobato M N, Leary L S, Simone P M. Treatment for latent TB in correctional facilities: a challenge for TB elimination. Am J Prev Med 2003; 24: 249-253. (Pubitemid 36349132)
32. Rodrigo T, Caylà J A, García de Olalla P, et al. Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987-2000. Int J Tuberc Lung Dis 2002; 6: 1091-1097. (Pubitemid 36054963)
33. García de Olalla P, Martínez-González M A, Caylà J A, et al. Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis 2002; 6: 1051-1057. (Pubitemid 36054958)
34. Marco A, Caylà J A, Serra M, et al. Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Eur Respir J 1998; 12: 967-971. (Pubitemid 28491676)
35. Pons M, García-Altés A. Qui som els ciutadans i ciutadanes de Barcelona. Situació demogràfica. In: La salut de la poblacióimmigrant a Barcelona. Barcelona, Spain: Agència de Salut Pública, 2008. [Catalan] http://www.bcn.cat/novaciutadania/pdf/ca/ estudis/salut-immigrants-ASPB-BCN-ca.pdf Accessed October 2011.
36. Orcau A, García de Olalla P, Caylà J A. La tuberculosi a Barcelona. Informe 2009. Barcelona, Spain: Agencia de Salut Pública, 2011. [Catalan] http://www.aspb.es/quefem/docs/TBC-2009.pdf Accessed October 2011.
37. Departament de Justicia de Catalunya. Descriptors estadístics de Serveis Penitenciaris i Rehabilitació. Barcelona, Spain: Genera litat de Catalunya. [Catalan] http://www.gencat.cat/justicia/estadistiques-serveis- penitenciaris/1-pob.html Accessed October 2011.
38. Baboolal S, Ramoutar D, Akpaka P E. Comparison of the QuantiFERON®-TB Gold assay and tuberculin skin test to detect latent tuberculosis infection among target groups in Trinidad & Tobago. Rev Panam Salúd Pública 2010; 28: 36-42.
39. Martín V, Caylà J A, Bolea Á, Castilla J. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis 2000; 4: 41-46. (Pubitemid 30059283)
40. Banu S, Hossain A, Uddin M K, et al. Pulmonary tuberculosis and drug resistance in Dhaka central jail, the largest prison in Bangladesh. PLoS One 2010; 5: e10759.
41. Moura L C, Ximenes R A, Ramos H L, et al. An evaluation of factors associated with taking and responding positive to the tuberculin skin test in individuals with HIV/AIDS. BMC Public Health 2011; 11: 687.